PubMed HealthSearch

Biomedical subjects

C R Marks

Publications and source records attributed to C R Marks.

8 recordsLinked to original sources

Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.

OBJECTIVE: To compare the relative safety and efficacy of azathioprine (AZA), methotrexate (MTX), and the combination of both in the treatment of active rheumatoid arthritis (RA). METHODS: Two hundred twelve patients with active RA were entered into a 24-week prospective, controlled, double-blind, multicenter trial and were randomly assigned to 1 of 3 treatment groups. RESULTS: One hundred fifty-eight patients finished 24 weeks of the study. There were no remissions seen but response rates were greater than 30% for all outcome measures. Combination therapy was not statistically superior to MTX therapy alone, but both combination therapy and MTX alone were superior to AZA alone when patients were analyzed by intent-to-treat and with withdrawals treated as therapy failures. If only patients who continued taking the therapy were analyzed, the mean improvement was greater for AZA therapy than for MTX, while the combination remained the most active. Adverse effects on the gastrointestinal tract and elevations of liver enzyme levels were the most frequent causes for discontinuations. CONCLUSION: Both combination therapy and MTX alone were superior to therapy with AZA alone for active RA but were not statistically different in their effect on outcome assessment.

Adult

Assessment of body composition in heart transplant patients.

Orthotopic heart transplantation (OHT) recipients often experience increased body weight (BW) following surgery. Using hydrostatic weighing (HW), this study assessed the body density (BD) and body composition of 17 white and seven black male OHT patients. It examined the cross-validity of the Jackson and Pollock seven and three site skinfold (SF) regression equations for predicting BD in these patients. We hypothesized that both prednisone (P) dose and months post-operative (MPO) would be inversely related to BD. The average of the last five of ten HW trials was used in computing BD. BW and % body fat (BF) were 88.5 +/- 17.8 kg (mean +/- SD) and 33.5 +/- 9.4%, respectively. The correlation coefficient between hydrostatically determined BD and BD determined via two of the three intercept revised Jackson and Pollock SF equations was r = 0.89, SE = 0.009. A polynomial regression model for BD using P dose and MPO provided a correlation coefficient of r = 0.71, SE = 0.015. Partial correlation techniques incorporating SF, age, MPO, and P dose indicated that neither P dose or MPO provided any significant additive effect, above SF and age, when predicting BD. We conclude that in OHT patients receiving glucocorticoids, the intercept revised Jackson and Pollock SF regression equations are generally applicable and associated with a SE of +/- 4 BF percentage points. Up to 49 months after OHT, both P dose and MPO are inversely related to BD but provide no additive value above SF for predicting BD.

Adult

Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis.

Rheumatoid arthritis (RA) is prevalent in Yakima Indians, a Native American tribe. HLA-DR4, the HLA specificity commonly associated with RA in Caucasians, is rare among the Yakima. Using a specific oligonucleotide probe that recognizes DR4 nucleotide sequences associated with RA, a rare HLA-Dw16 gene was identified in 83% of Yakima patients with RA and in 60% of Yakima control subjects. This shared sequence encodes a discrete class II epitope that is highly correlated with RA in both DR4 positive and DR4 negative individuals.

Adult

Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.

The liver histology of 52 patients treated with intermittent low dose pulse methotrexate for rheumatoid arthritis was evaluated using a modification of the Roenigk grading system. Patients studied had had an average of 3.2 years of treatment or had received 1.7 g methotrexate. No patient had cirrhosis; 15 (29%) patients had evidence of mild fibrosis. Histological abnormalities were not predicted by liver function test changes, with the exception that hypoalbuminaemia occurred in 60% of those with grade IV (modified criteria) findings. The need for liver biopsy in patients with rheumatoid arthritis treated with methotrexate before two years or 1500 mg of treatment has not been established. Whether serial liver biopsies will be needed beyond this time has yet to be determined.

Adult

Physiological responses to nine different exercise:rest protocols.

This study determined the metabolic responses to different exercise:rest protocols during circuit exercise using hydraulic resistance. In experiment 1, nine subjects underwent nine different 27 min exercise circuits. There were three variations of three exercise:rest protocols (2:1, 1:1, 1:2). The VO2 for the nine circuits averaged (mean +/- SEM) 1.94 +/- 0.03 l.min-1 (43% of treadmill VO2max), with the largest difference between the protocols being 13%. Heart rate averaged 152.2 +/- 3.1 beats.min-1, with the largest difference between the protocols being 8%. Increasing the exercise duration per minute or the number of exercise bouts per minute had minimal effects on the mean VO2 and heart rate response to hydraulic resistive exercise. In experiment 2, nine subjects underwent three different 9 min exercise circuits using exercise:rest protocols of 2:1, 1:1, and 1:2 while work and VO2 were simultaneously measured. Surprisingly, increases in work were not necessarily accompanied by corresponding increases in VO2.

Adult

Resistance weight training during caloric restriction enhances lean body weight maintenance.

To assess the individual and combined effects of weight loss and weight training on body weight and body composition, 40 obese women were randomly assigned to one of four groups for an 8 wk weight-loss study. These groups were control (C); diet without exercise (DO); diet plus weight training (DPE); and weight training without diet (EO). Body weight decreased for DO (-4.47 kg) and DPE (-3.89 kg) compared with C (-0.38 kg) and EO (0.45 kg). Lean body weight (LBW) increased for EO (1.07 kg) compared with DO (-0.91 kg) and C (-0.31 kg) and for DPE (0.43 kg) compared with DO. Upper-arm muscle areas (determined by radiograph) increased for DPE (11.2 cm2) and EO (10.4 cm2) compared with C (2.7 cm2) and DO (2.1 cm2). It was concluded that weight training results in comparable gains in muscle area and strength for DPE and EO. Adding weight training exercise to a caloric restriction program results in maintenance of LBW compared with DO.

Adult

Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention.

The incidence of coronary heart disease risk factors and the effects of 20 weeks of diet and exercise were studied in 36 obese adolescents. Values for the following risk factors were determined: serum triglyceride level, high-density lipoprotein-cholesterol level, total cholesterol level, systolic and diastolic BP, maximum work capacity, obesity, and presence of coronary heart disease in the family history. Of the subjects, 97% had four or more risk factors. Two subjects possessed all eight risk factors. The adolescents were randomly assigned to either a control, diet therapy and behavior change, or exercise, diet therapy, and behavior change group. From pre- to posttreatment, a 14.8% and 41.4% reduction in multiple risk was noted for the latter two groups, respectively. No significant difference between the control group and the diet and behavior change group was found. In contrast, the exercise-diet-behavior change group reduced multiple risk (P less than .01) more than either of the other groups. It was concluded that obese adolescents are at high risk for the development of coronary heart disease and that exercise in addition to moderate dietary restriction can result in the reduction of multiple coronary heart disease risk.

Adolescent